Steward Partners Investment Advisory, LLC Adaptimmune Therapeutics PLC Transaction History

Steward Partners Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$0.72 - $1.43 $1,440 - $2,860	-2,000 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$3.23 - $5.41 $6,460 - $10,820	2,000 New	2,000 $8,000
Q4 2018 Jan 15, 2019	SELL	$3.76 - $14.16 $7,520 - $28,320	-2,000 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$6.68 - $8.74 $13,360 - $17,480	2,000	2,000 $13,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $96.4M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.